Topical minocycline compositions and methods of using the same
AssigneeLaboratory Skin Care, Inc.
InventorZahra Mansouri
Life of this patent
Estimating the term…
Abstract
Topical minocycline compositions with reduced fluorescence are provided. In some instances, the compositions include an amount of a minocycline active agent associated with porous calcium particles. Also provided are methods of using the compositions, e.g., in the treatment of acne.
Claims20
A topical minocycline composition comprising a porous, ceramic calcium phosphate particles having a pore size ranging from 2 nm to 100 nm and loaded with a minocycline active agent, wherein the amount of minocycline active agent associated with the particles ranges from 0.1 to 100 mg/g and the composition is a formulation configured to be applied to a keratinized skin surface location of a mammal and is chosen from a lotion, gel, cream and ointment, and further wherein the topical minocycline composition exhibits reduced fluorescence as compared to a control.
A method comprising applying to a keratinized skin surface location of a subject a topical minocycline composition comprising porous, ceramic calcium phosphate particles having a pore size ranging from 2 nm to 100 nm and loaded with a minocycline active agent, wherein the amount of minocycline active agent associated with the particles ranges from 0.1 to 100 mg/g and the composition is a formulation configured to be applied to a keratinized skin surface location of a mammal and is chosen from a lotion, gel, cream and ointment, and further wherein the topical minocycline composition exhibits reduced fluorescence as compared to a control.
A method of treating acne in a subject, the method comprising:
- applying to a keratinized skin surface location of a subject known to have acne a topical minocycline composition comprising porous calcium phosphate particles having a pore size ranging from 2 nm to 100 nm and loaded with a minocycline active agent, wherein the amount of minocycline active agent associated with the particles ranges from 0.1 to 100 mg/g and the composition is a formulation configured to be applied to a keratinized skin surface location of a mammal and is chosen from a lotion, gel, cream and ointment, and further wherein the topical minocycline composition exhibits reduced fluorescence as compared to a control.
Dependencies are inferred from the claim text.